Next Generation Cancer Diagnostics Market Size, Emerging Trends and Outlook to 2022: Hexa Reports

Hexa Reports

Market Research Reports and Insightful Company Profiles

Next Generation Cancer Diagnostics Market Analysis, Share

and Size, Emerging Trends, Overview and Outlook, Growth

And Segment Forecasts To 2022

Global next generation cancer diagnostics market is anticipated to reach USD 20.25 billion by 2022

growing at an estimated CAGR of 32.0% from 2015 to 2022, according to a new report by Grand View

Research Incorporated. Rising incidence of oncology diseases is anticipated to drive the demand for next

generation cancer diagnostic tests that are expected to enhance early diagnosis and efficient prognosis

of various forms of cancers is a factor expected to positively influence sector growth over the forecast

period.

Cancer diagnostics industry is estimated to witness lucrative growth over the forecast period majorly

due to rising number of technologically advanced products in the field of companion diagnostics,

providing more precise testing results combined with therapeutic monitoring early diagnosis of cancer.

Browse Detail Report With TOC @

http://hexareports.com/report/next-generation-cancer-diagnostics-market/details

Moreover, there is a significant shift observed from traditional laboratory testing to rapid point of care

testing, which fuels growth in the market owing to expected commercialization of technologically

advanced range of products including diagnostic kits, instruments, and reagents.

Furthermore, supportive government initiatives in order to increase the number of research projects

with respect to oncology and preventative diagnosis is expected to be attributive for growth in this

Hexa Reports

Market Research Reports and Insightful Company Profiles

sector overthe coming years. Additionally, application of tumor diagnostics in epigenetic analysis and

CTC enumeration for monitoring tumorigenesis is expected to support projected growth over the

forecast period.

Further key findings from the report suggest:

 RT-PCR & multiplexing accounted...